Brief: Sprint Bioscience Q2 Operating Result Swings To Loss SEK 10.1 Million
Aug 26 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 NET SALES SEK 5.8 MILLION VERSUS SEK 19.3 MILLION YEAR
AGO
* Q2 OPERATING LOSS SEK 10.1 MILLION VERSUS PROFIT SEK 4.9
MILLION YEAR AGO
* PROVIDES NO OUTLOOK
Source text for Eikon: ID:nWkr2KsjJ3
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program